Zobrazeno 1 - 10
of 395
pro vyhledávání: '"Kenneth D. Burman"'
Autor:
William Kuenstner, MD, Po Zhao, MD, Wen Lee, MD, Carlos Garcia, MD, Kenneth D. Burman, MD, Leila Shobab, MD
Publikováno v:
AACE Clinical Case Reports, Vol 10, Iss 2, Pp 63-66 (2024)
Background/Objective: Cribriform-morular thyroid carcinoma (CMTC) was considered a variant of papillary thyroid carcinoma (PTC) but is a separate entity in the 2022 World Health Organization classification. CMTC has an association with familial adeno
Externí odkaz:
https://doaj.org/article/9963b32b81004572a5d54ae110d95ffb
Autor:
Chaitra Gopinath, Hanna Crow, Sujata Panthi, Leonidas Bantis, Kenneth D. Burman, Chitra Choudhary
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 33, Iss , Pp 100321- (2023)
Background: The incidence of thyroid cancer has increased over the last three decades with studies showing incidence of thyroid cancer is higher among patients with Graves’ Disease (GD) when compared to Toxic multinodular goiter.1 We conducted a re
Externí odkaz:
https://doaj.org/article/5c57509375c34b479c6d8d51c221ff4e
Autor:
Cristiane J. Gomes-Lima, Leila Shobab, Di Wu, Dorina Ylli, Athanasios Bikas, Matthew McCoy, Rebecca Feldman, Wen Lee, Sarika N. Rao, Kirk Jensen, Vasily Vasko, Luiz Claudio Castro, Jacqueline Jonklaas, Leonard Wartofsky, Kenneth D. Burman
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Management of metastatic radioiodine refractory differentiated thyroid cancer (DTC) can be a therapeutic challenge. Generally, little is known about the paired molecular profile of the primary tumor and the metastases and whether they harbor the same
Externí odkaz:
https://doaj.org/article/b89473ae59a849c292ed9ec2795f6b1a
Autor:
Hui Zheng, Victoria Lai, Jana Lu, Di Hu, Jin K. Kang, Kenneth D. Burman, Leonard Wartofsky, Jennifer E. Rosen
Publikováno v:
The American Journal of Surgery. 225:694-698
We employed Machine Learning (ML) to evaluate potential additional clinical factors influencing replacement dosage requirements of levothyroxine.This was a retrospective study of patients who underwent total or completion thyroidectomy with benign pa
Autor:
Cristiane J. Gomes-Lima, Sungyoung Auh, Shilpa Thakur, Marina Zemskova, Craig Cochran, Roxanne Merkel, Armando C. Filie, Mark Raffeld, Snehal B. Patel, Liqiang Xi, Leonard Wartofsky, Kenneth D. Burman, Joanna Klubo-Gwiezdzinska
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
Background: Thyroid ultrasound (US), fine needle aspiration biopsy (FNAB), and molecular testing have been widely used to stratify the risk of malignancy in thyroid nodules. The goal of this study was to investigate a novel diagnostic approach for cy
Externí odkaz:
https://doaj.org/article/feeaec14157a41b7ac321e789207b2e8
Publikováno v:
Molecular Cancer, Vol 17, Iss 1, Pp 1-14 (2018)
Abstract Thyroid cancer incidence is increasing at an alarming rate, almost tripling every decade. In 2017, it was the fifth most common cancer in women. Although the majority of thyroid tumors are curable, about 2–3% of thyroid cancers are refract
Externí odkaz:
https://doaj.org/article/8b29411a86ca4cefb1a6f254470ba920
Autor:
Kenneth D. Burman
Publikováno v:
Clinical Thyroidology. 35:180-182
Clinician Survey Shows Differences in the Approach to and Treatment of Thyroid Eye Disease Worldwide
Autor:
Kenneth D. Burman
Publikováno v:
Clinical Thyroidology. 35:61-63
Autor:
Joanna Klubo-Gwiezdzinska, John Costello Jr, Kirk Jensen, Aneeta Patel, Rok Tkavc, Douglas Van Nostrand, Kenneth D Burman, Leonard Wartofsky, Vasyl Vasko
Publikováno v:
Endocrine Connections, Vol 6, Iss 7, Pp 469-478 (2017)
Background: Amifostine is a potent scavenger of reactive oxygen species that is used for the salivary gland protection during therapy with radioactive iodine for thyroid cancer. There are no data on the potential effect of amifostine on thyroid cance
Externí odkaz:
https://doaj.org/article/19b9866d1f2a490a850174fada7c7fb8
Autor:
Sasan Fazeli MD, Edina Paal MD, Jessica H. Maxwell MD, Kenneth D. Burman MD, Eric S. Nylen MD, Shikha G. Khosla MD, MHA
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 7 (2019)
Context . Anaplastic thyroid cancer (ATC) is an aggressive tumor with a median survival of 3 to 9 months, a 1-year survival of less than 10% and without definitive therapies. Recently, in BRAF V600E mutated ATCs, new targeted therapy using a combinat
Externí odkaz:
https://doaj.org/article/a8688cca4a1848e8b639b3f7a67218b3